Quarter Financials
AstraZeneca PLC (AZN)
$72.52
+0.73 (+1.02%)
Income Statement
Balance Sheet
Cash Flow
Year
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
Net Income | 901 | 1,640 | 360 | 386 | -347 | -1,652 | 550 | 1,561 |
Dividend Paid | - | -1,393 | - | -2,971 | - | -1,387 | - | -2,469 |
Retained Earnings | -574 | -2,471 | -1,657 | -1,228 | 1,710 | 2,200 | 5,335 | 4,089 |
---|
Year
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
Capital Expenditure | -554 | -1,111 | -543 | -363 | -718 | -660 | -353 | -469 |
Net PPE | 9,449 | 9,227 | 9,627 | 10,015 | 10,171 | 10,162 | 9,031 | 8,849 |
---|
Year
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
New Purchases | - | -10 | -180 | 6 | -4 | -24 | -321 | 190 |
Intangible and Goodwill | 11,765 | 11,798 | 20,081 | 19,997 | 19,963 | 19,821 | 19,707 | 19,820 |
---|